一个疾病模型预测了使用修改的梅奥得分的性结肠炎患者的安慰剂反应和缓解状态
Anita Moein1, Jurgen Langenhorst2, Elodie L Plan2
1Genentech, Inc., South San Francisco, California, USA.
Clinical and translational science
|September 18, 2023
概括
项目反应理论模型可以使用频繁的直肠出血和便频率数据来预测性结肠炎 (UC) 临床状态,以估计不太频繁的内镜分数. 这种方法有助于临床试验设计和患者评估.
科学领域:
- 胃肠病学 胃肠病学
- 临床试验 临床试验
- 生物统计学 生物统计学
背景情况:
- 梅奥临床评分 (MCS) 评估性结肠炎 (UC) 活动,修改后的MCS (mMCS) 关注直肠出血 (RB),便频率 (SF) 和内镜检查 (ENDO).
- RB和SF经常被测量,而ENDO的频率较低,在临床试验评估中造成数据缺口.
- 项目响应理论 (IRT) 提供了一个统计框架,利用可用的数据来预测未观察到或较少测量的变量.
研究的目的:
- 开发和验证一种IRT模型,用于预测UC患者的纵向mMCS亚值.
- 评估模型在UC临床试验中预测安慰剂反应和缓解状态的能力.
- 评估IRT模型在UC药物开发中为临床试验设计和决策提供信息的有用性.
主要方法:
- 开发了一个有界的整数IRT模型,使用了四个ETROLIZUMABIII期UC研究的数据.
- 建模的纵向mMCS分值 (RB,SF,ENDO),安慰剂反应和缓解.
- 利用RB和SF数据来预测ENDO分数和整体mMCS.
- 外部验证了该模型,使用来自五项独立UC研究的安慰剂手臂.
主要成果:
- IRT模型准确预测了纵向mMCS数据,包括安慰剂反应.
- 缓解状态的预测很好,在诱导和维护阶段的超低预测最小.
- 外部验证证实了该模型在预测mMCS分数和缓解方面具有充足的性能.
结论:
- 开发的IRT模型有效地预测UC患者的纵向mMCS,利用频繁可用的数据.
- 这种预测模型证明了优化临床试验设计,患者监测和UC治疗开发中的评估的实用性.
- 这些发现支持使用IRT模型,以便在UC临床研究中更有效,更知情地做出决策.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
168
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
168
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
354
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Inflammatory Bowel Disease I: Ulcerative Colitis
213
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144
Inflammatory Bowel Disease II: Crohn's Disease
285
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
285


